Atherosclerosis is characterised by the infiltration of macrophages at sites of inflammation within the vessel wall and the release of myeloperoxidase (MPO), which forms hypochlorous acid (HOCl) and hypothiocyanous acid (HOSCN). HOCl is a damaging oxidant strongly implicated in the development of atherosclerosis. Preferential formation of HOSCN occurs under conditions where thiocyanate ions are elevated, as is the case in the plasma of smokers. HOSCN reacts selectively with thiols, which can result in a greater extent of enzyme inactivation leading to more extensive cellular damage than HOCl at susceptible sites; this may contribute to the increased risk of atherosclerosis seen in smokers. In this study, we show that the exposure of macrophages to HOSCN results in a time-and dose-dependent increase in the mRNA expression and release of proinflammatory cytokines and chemokines, including monocyte chemotactic protein 1, tumour necrosis factor alpha, and interleukins 6, 8 and 1β. Only at high oxidant concentrations (>200 µM)
INTRODUCTION
Atherosclerosis is a chronic inflammatory disease that is characterised by the accumulation and infiltration of leukocytes within the vessel wall, which trigger lipid deposition resulting in lesion formation and the progressive narrowing of affected blood vessels [1] . Macrophages comprise the largest subset of leukocytes within the lesion, and are responsible for accumulating excessive lipid resulting in "foam cell" formation, with macrophage cell death contributing to necrotic core formation, lesion destabilisation and ultimately thrombosis [1, 2] . In addition, macrophages release a battery of cytokines and chemokines, including monocyte chemotactic protein 1 (MCP-1), tumour necrosis factor alpha (TNFα), interleukin 6 (IL-6), interleukin and interleukin 1β (IL-1β), which propagate disease by exacerbating inflammation and vascular cell dysfunction [3] . Tissue-resident macrophages (together with neutrophils) have also been implicated in the release of the peroxidase enzyme, myeloperoxidase (MPO) [4] , which is present in elevated amounts in atherosclerotic tissue [5] .
MPO is a heme enzyme that catalyses the reaction of halide and pseudo-halide ions with hydrogen peroxide (H2O2) to form hypohalous acids. Hypohalous acids are oxidants, and play an important role in the immune system by killing bacteria and other invading pathogens [6, 7] . The overproduction of hypohalous acids by MPO during chronic inflammation, has however, been strongly linked with the host tissue damage and the development of disease, particularly atherosclerosis [7, 8] . MPO is also recognised as both a risk factor for the development of coronary artery disease [9] and a prognostic factor determining patient outcome following cardiovascular events [10] . Under physiological conditions, MPO utilises predominantly chloride ions (Cl -) to produce hypochlorous acid (HOCl), which is a potent and indiscriminate oxidant, that reacts rapidly with most biological molecules [7, 11] . MPO also utilises thiocyanate (SCN -) to produce hypothiocyanous acid (HOSCN) [12] . SCNhas a very high specificity for MPO (~730-fold higher than Cl -) [13] , and is therefore able to compete effectively with the more abundant Clions present under physiological conditions, which reduces the amount of HOCl formed [11, 14] . Unlike HOCl, 5 HOSCN is a selective oxidant, which reacts predominantly with free Cys or thiol (R-SH) residues [11, 12, 15] . Therefore, conditions that favour HOSCN production will result in an altered pattern and extent of cellular damage to that which occurs with HOCl (reviewed [11, 16] ).
Currently, the role of HOSCN in the development atherosclerosis is unclear and controversial. The detoxification of cyanide on inhalation of cigarette smoke results in elevated plasma SCNlevels [14] , which is associated with a higher incidence of cardiovascular disease [17] .
In smokers, it is reported that serum SCNlevels correlate with an increased deposition of lipid and expression of markers of foam cell formation in the arterial wall [18, 19] . However, SCNsupplementation of transgenic mice that are both genetically predisposed to develop atherosclerosis, and over-express human MPO, results in decreased in lesion formation [20] . Moreover, high plasma SCNlevels have been associated with improved long-term survival in patients following myocardial infarction [21] . Similarly, comparison of the reactivity of HOCl and HOSCN in different cellular models gives mixed results (reviewed [16] ). There are clear examples where increased targeting of susceptible thiol-containing proteins by HOSCN results in more extensive enzyme inactivation compared to HOCl, for example, GAPDH and other glycolytic enzymes [15, 22] , protein tyrosine phosphatases [23, 24] , caspases [25, 26] , ATPases [27, 28] , which can lead to a greater extent of cell death [25, 29] . However, the addition of SCNto enzymatic MPO/H2O2/Clsystems can also protect cells from HOCl-mediated cytotoxicity [30] [31] [32] .
It has been shown previously that HOSCN can stimulate the increased expression of the cellular adhesion molecules E-selectin, intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) on exposure to human umbilical vein endothelial cells (HUVEC), which is attributed to the activation of redox-sensitive transcription factors, including nuclear factor κB (NF-κB) [33] . In light of this, and the conflicting data regarding the role of SCNin the pathogenesis of atherosclerosis, we performed experiments to assess the effect of HOSCN on the activation of pro-inflammatory signalling and survival pathways using a well-characterised human macrophage cell model, the THP-1 monocytic cell line, differentiated to macrophages by 6 exposure to phorbol myristate acetate (PMA). This is of importance as macrophages play an integral role in lesion development, and it is well established that exposure to HOSCN can perturb the redox environment in this cell type to promote cellular dysfunction [15, 22, 25] .
MATERIALS AND METHODS
Materials and Reagents -All aqueous reagents were prepared using nanopure water, filtered through a four-stage milli-Q system. All reagents were from Sigma-Aldrich (Castle Hill, NSW, Australia) unless otherwise noted. HOSCN was prepared enzymatically with lactoperoxidase (LPO; from bovine milk: Calbiochem, Kilsyth, VIC, Australia) using LPO/H2O2/SCNas described previously [25, 34] . The concentration of HOSCN was determined by quantifying the consumption of 5-thio-2-nitrobenzoic acid (TNB) at 412 nm using a molar absorption coefficient ε of 14,150 M -1 cm -1 [35, 36] . Experiments were also performed with HOSCN that had been allowed to decompose (at 22 °C, in the dark, > 2 weeks; dHOSCN) to assess the contribution from decomposition products.
Cell culture and treatment -The human monocytic cell line THP-1 (TIB-2; ATCC, Manassas, Virginia), was cultured under sterile conditions in RPMI media supplemented with 10% (v/v) foetal bovine serum (Bovogen Biologicals, Keilor East, VIC, Australia), 2 mM L-glutamine (Lonza, Basel, Switzerland), 100 units/mL penicillin (Sigma-Aldrich), and 10 µg/mL streptomycin (Lonza) in 175 cm 2 cell culture flasks (Corning, NY, USA) at 37 °C in a humidified atmosphere of 5% CO2 with routine passaging every 2 -4 days. The monocytes were differentiated into macrophages by seeding at density of 1 x 10 6 cells/well in 12 well tissue culture plates in culture media containing 50 ng/mL PMA for 72 h [37] . Cells were washed in HBSS prior to treatment with pathophysiological HOSCN concentrations (0 -250 µM) for 1 h at 37 °C in a humidified atmosphere of 5% CO2. Following treatment, the cells were washed with HBSS and re-cultured in cell media for either 3, 6 or 24 h at 37 °C in a humidified atmosphere of 5% CO2.
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Assessment of cellular function -Cell viability was determined by the lactate dehydrogenase (LDH) release assay [38] . Quantification of total cellular thiols following treatment with HOSCN was assessed using the ThioGlo assay, using a reduced glutathione (GSH) standard curve [35] and was normalised to the cell protein concentration assessed by the BCA assay. Mitochondrial function was assessed by measuring alterations in mitochondrial membrane potential using the Mitoprobe JC-1 (tetraethyl-benzimidazolyl-carbocyanine iodide) assay kit (Life Technologies, Carlsbad, CA, USA) with flow cytometry as previously described [29] . Secretion of various cytokines / chemokines was quantified in clarified cell culture supernatants by ELISA, according to the manufacturer's instructions (Peprotech, Rocky Hill, NJ, USA).
RNA extraction and cDNA synthesis -RNA was extracted using ReliaPrep RNA Cell Miniprep
System kits following the manufacturer's instructions (Promega, Madison, WI, USA). Quantity and yield of total RNA extracted was assessed using a Nanodrop 2000C spectrophotometer (Thermo Scientific, Waltham, MA, USA). RNA samples were normalised to 500 ng total RNA per reaction using RNase free water (Promega, Madison, WI, USA) and cDNA synthesised using an iScript cDNA synthesis kit following manufacturer's protocol (Bio-Rad, Hercules, CA, USA).
Quantitative real-time polymerase chain reaction (qPCR) -
The expression of mRNA for the inflammatory cytokines were assessed by qPCR using the primer sequences outlined in Table 1 , designed using the National Centre for Biotechnology Information (NCBI; Bethesda, MD, USA) nucleotide database and accompanying primer design software, coupled with iQ SYBR Green Supermix following manufacturer's protocol (Bio-Rad, Hercules, CA, USA). Cycling consisted of an activation step of 95 °C for 3 min, followed by denaturation at 95 °C for 30 s annealing at 60 °C for 30 s, and extension at 72 °C for 30 s repeated over 40 cycles, before a final denaturation at 95 °C for 2 min. Relative mRNA concentrations of the genes of interest were normalised against the corresponding relative mRNA concentrations of the 18S ribosomal RNA (18S) and β2microglobulin (β2M) house-keeping genes, with the resultant data expressed as a fold increase in the genes of interest over cells incubated in the presence of decomposed HOSCN [39] . 
SDS-PAGE and Western blotting -

RESULTS
HOSCN is consumed by macrophages resulting in loss of thiols and cell viability
Initial studies examined the consumption of HOSCN by THP-1 macrophages exposed to the previous work with other cell types (e.g. [29] ). (Fig. 2) . With IL-1β and the chemokines MCP-1 and IL-8, the most pronounced increase in mRNA expression was apparent 24 h post-HOSCN treatment, whereas with cytokines IL-6 and TNFα, a greater extent of mRNA expression was seen 6 h post-HOSCN treatment (Fig. 2) . The effect of HOSCN treatment on the ability of THP-1 macrophages to secrete MCP-1, IL-6, IL-8 and
HOSCN upregulates pro-inflammatory cytokines and chemokines
TNFα was also assessed. A significant increase in the concentration of each cytokine / chemokine in the cellular supernatant compared to the non-treated control cells was observed 24 h after exposure of the THP-1 macrophages to HOSCN (250 µM) by ELISA. This is consistent with increased expression and secretion of MCP-1, IL-6, IL-8 and TNFα by THP-1 macrophages exposed to HOSCN (Fig. 3) .
HOSCN-induced upregulation of cytokine / chemokine expression is dependent on NF-κB
The effect of HOSCN treatment on the activation of MAPK signalling cascades and the transcription factor NF-κB was examined as these pathways are redox-sensitive [40] and known to promote cytokine and chemokine release [41] . Western blotting studies to assess the extent of phosphorylation of ERK1/2, p38 and JNK as a measure of MAPK activation were performed on THP-1 macrophages exposed to HOSCN (0 -250 µM) for 15 min. However, high basal MAPK protein phosphorylation was seen in the untreated control cells, which did not alter with HOSCN treatment (data not shown). This may be associated with the addition of PMA to the cells to promote macrophage differentiation, which makes it difficult to assess the effect of HOSCN on MAPK signalling. In contrast, increased nuclear translocation of the p65 subunit of NF-κB was apparent on treatment of macrophages with HOSCN (250 µM) for 1 h (Fig. 4A) , consistent with activation of this transcription factor. 11 To examine whether NF-κB played a role in the elevated cytokine and chemokine expression, experiments were performed to examine MCP-1, IL-6, IL-8, TNFα and IL-1β expression in THP-1 macrophages that had been pre-incubated with the specific inhibitor BAY117085 (20 µM) for 30 min prior to exposure HOSCN. This resulted in a reduction in the mRNA expression of all of the cytokines and chemokines, which was statistically significant in the case of IL-8, TNFα and IL-1β (Fig. 4B) . Pre-treatment of the THP-1 macrophages with BAY117085, also significantly attenuated cell death (Fig. 4C) as measured by LDH release at 24 h post-exposure to HOSCN (250 µM).
DISCUSSION
Macrophages play an integral role in promoting inflammation and the formation of lesions within the arterial wall, which together drive the development of atherosclerosis [1] . Lesions are enriched with enzymatically-active MPO, which co-localises with macrophages [5] , suggesting that these cells will be key targets for MPO-derived oxidants. It is well established that HOCl causes significant disruption to macrophage function, including perturbing intracellular Ca 2+ , depleting antioxidants, and inactivating enzymes, which culminate in both necrotic and apoptotic cell death [25, 42, 43] . The presence of SCNpromotes the formation of HOSCN by MPO, which can also disrupt macrophage function, by selectively targeting thiol-dependent enzymes [15, 22, 25] . In this study, we show for the first time that HOSCN can upregulate the expression of pro-inflammatory cytokines and chemokines in macrophages via activation of the transcription factor NF-κB, which also plays a role in promoting cell death.
This could be a pathway that contributes to exacerbation of inflammation in the arterial wall, and accelerated lesion development. The concentrations of HOCl and HOSCN formed in vivo in a chronic inflammatory setting are not known. The concentration of HOCl produced in vivo can be estimated as ca. 200 -500 µM from calculations based on either the activation of a circulating concentration of human neutrophils [44] or from the reported levels of MPO present in human lesions [5] , though higher mM doses have been reported at inflammatory sites [45] . The concentration of HOSCN produced in vivo will be dependent on the availability of the precursor SCN -. It is noted that the concentrations at which HOSCN stimulates the activation of NF-κB and cytokine / chemokine release (> 100 µM) are likely only to be formed in the presence of supraphysiological amounts of SCN -, which are generally only achievable with supplementation or on cigarette smoking [14] .
The THP-1 macrophages consumed HOSCN over a period of 1 h, which is a similar time course to previous studies with murine J774A.1 macrophage-like cells, though the total extent of oxidant consumption differed, with the THP-1 macrophages consuming 80% of the initial HOSCN after 1 h, compared with 30% in the experiments with the murine cells [25] . The greater oxidant consumption seen with the THP-1 macrophages did not appear to result in more extensive depletion of intracellular thiols or cell death compared to the J774A.1 cells under comparable treatment conditions. This may reflect that HOSCN is more readily metabolised by THP-1 macrophages compared to J774A.1 cells. Thus, thioredoxin reductase (TrxR) has been implicated as a key pathway responsible for the cellular metabolism of HOSCN, with inhibition of this enzyme shown to sensitise mammalian cells to HOSCN-mediated toxicity [30] . In this study, the expression and activity of TrxR in the THP-1 macrophages in the presence and absence of HOSCN was not assessed, though J774A.1 cells have been reported to have reduced TrxR activity compared to other macrophage cell lines [46] . That concentrations of HOSCN > 100 µM are required to see activation of NF-κB may reflect the point at which this antioxidant defensive pathway becomes overwhelmed.
Alternatively, there may be differential reactivity of HOSCN with cell membrane components, including extracellular membrane receptors, which could also vary on THP-1 macrophages compared to J774A.1 cells.
We demonstrate that exposure of THP-1 macrophages to HOSCN results in the increased 13 expression of pro-inflammatory cytokines (IL-6, TNFα, IL-1β) and chemokines (MCP-1, IL-8) in a dose-and time-dependent manner (Fig. 2) , which is concomitant with the release of active forms of these signalling molecules by the macrophages (Fig. 3) . MCP-1 and IL-8 promote the migration of leukocytes and activation of the endothelium, which together can contribute to lesion development by increasing the uptake of low-density lipoprotein (LDL) [47] . The cytokines IL-6, TNFα and IL-1β are critical mediators of both acute and chronic inflammation [41] and have also been implicated as strong independent risk factors for the development of cardiovascular disease [48] . The cytokines IL-6, TNFα and IL-1β are reported to signal through type 1 cytokine receptors, whereas the chemokine IL-8 interacts with G protein-coupled receptors (GPCRs) [41] , suggesting that HOSCN could potentially influence multiple pro-inflammatory signalling cascades relevant to lesion formation in atherosclerosis.
The increased expression of cytokines and chemokines is attributed to the HOSCN-mediated activation of NF-κB, as pre-treatment with BAY117085 prevents the increased cytokine and chemokine expression and the associated loss in cell viability (Fig. 4) , though the ability of this inhibitor to prevent the translocation of the p65 subunit of NF-κB was not directly measured in this study. NF-κB is regulated by IκB proteins, which bind to the protein subunits and mask their DNA binding domains. The activity of the IκB proteins, including IκBα, is controlled by phosphorylation by upstream IκB kinases (IKK) [49] . BAY117085 is an irreversible inhibitor of IκBα phosphorylation [50] , suggesting that HOSCN acts on the canonical (classical) pathway of NF-κB activation, leading to phosphorylation of IκBα and subsequent release and nuclear translocation of NF-κB [51] . These data support previous studies in HUVEC exposed to HOSCN, where increased expression of E-selectin, ICAM-1 and VCAM-1 is attributed to activation of NF-κB [33] .
In light of the previous studies showing targeting of thiols in macrophages exposed to HOSCN [15, 25] , the mechanism involved in the activation of NF-κB is likely to be related to alterations in the cellular redox environment. Reactive oxygen species (ROS) are known to 14 influence the activation of NF-κB via the canonical signalling pathway, which is characterised by binding of inflammatory molecules, including cytokines, to Toll-like receptors (TLR), tumour necrosis factor receptors (TNFR) and interleukin-1 receptors (IL-1R) [40, 49, 52] . Exogenously added oxidants such as H2O2, can regulate NF-κB activation by inducing the phosphorylation of IκBα, or by influencing the activity of IKK (reviewed [49] ). It has also been demonstrated that the extracellular Cys-rich domains of TNFR are sensitive to oxidation by externally generated oxidants [53] , which can promote the activation of NF-κB [54] . This could be important in THP-1 macrophages exposed to HOSCN, particularly as the increased expression of cytokines and chemokines is observed under treatment conditions where no intracellular thiol loss is apparent.
In this study, it was not possible to assess whether HOSCN increased the phosphorylation of the MAPK proteins ERK1/2, p38 or JNK, owing to the relatively high extent of phosphorylation of these proteins, when assessed following 1 h incubation of the macrophages in the presence and absence of oxidant. However, evidence for MAPK activation has been reported in previous experiments with J774A.1 macrophages and HUVEC exposed to HOSCN [23, 33, 55] . The significant basal level of MAPK phosphorylation seen in the THP-1 macrophages may be related to the pre-treatment of the cells with PMA to promote differentiation. This is a limitation of the current study, as PMA is an activator of protein kinase C, which is also reported to influence NF-κB activation (reviewed [51] ). However, HOSCN clearly increases the extent of nuclear translocation of the NF-κB p65 subunit over and above that seen in the control, non-treated cells. Similarly, a transcriptional upregulation of cytokine and chemokine expression and secretion is not seen to the same extent in control cells, which is analogous to the activation of NF-κB and cell adhesion molecule upregulation seen in HUVEC exposed to HOSCN [33] .
Exposure of THP-1 macrophages to HOSCN for 1 h did not cause a significant extent of cell death, when viability was determined immediately after oxidant treatment, in agreement with previous studies with murine macrophages [15, 25] . However, cell death reflected by increased leakage of LDH, was observed with ≥ 200 µM HOSCN, following re-incubation of the macrophages in the absence of oxidant for 24 h. Again, this could reflect the concentration at which the TrxR activity within the macrophages becomes saturated. In this study, the specific pathway responsible for cell death was not examined, though a role for NF-κB is apparent, as pre-treatment of the cells with BAY117085 mitigated the cytotoxicity induced by HOSCN (Fig. 5 ). NF-κB is an important regulator of programmed cell death, by both apoptotic and necrotic pathways (reviewed [56] ). Binding to the TNFR in particular, triggers the activation of a complex series of signalling cascades that can determine cell fate by either promoting survival or death by programmed apoptosis and necrosis [56] . Evidence for cell death by both apoptotic and necrotic pathways was apparent in previous work with murine macrophages exposed to HOSCN, which was associated with increased mitochondrial release of cytochrome c [25] . However, this is consistent with HOSCN inducing changes in mitochondrial membrane permeability, which is not seen in analogous experiments with THP-1 macrophages.
In summary, we provide evidence for a critical role of NF-κB as a mediator of both cell survival and pro-inflammatory signalling on exposure of human THP-1 macrophages to HOSCN. This is a novel pathway by which HOSCN could act to promote inflammation within the vascular setting in the presence of elevated levels of SCN -, and is particularly significant given the strong association between elevated circulating levels cytokines, including IL-1β, IL-6 and TNFα, and risk of developing atherosclerosis [48] . These results highlight a role for HOSCN as an inducer of stress-related, survival, signalling cascades, which can activate both repair and adaptive pathways, or promote apoptotic signalling and necrosis. Low concentrations of HOSCN may therefore have a protective function, but high amounts can promote cellular dysfunction. Overall, these data help to rationalise the accelerated development of atherosclerosis seen in smokers, and provide a greater understanding as to how SCNcould potentially modulate the development of disease during chronic inflammation. 
